Showing results (1681-1690 of 1,814) with videos related to

Sort By:
Pageof 182
The American Journal of Surgical Pathology|January 15, 2014
Comprehensive genomic profiling of relapsed and metastatic adenoid cystic carcinomas by next-generation sequencing reveals potential new routes to targeted therapiesJeffrey S Ross, Kai Wang, Janna V Rand, et al.
Kidney International|June 11, 2016
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsFrank B Cortazar, Kristen A Marrone, Megan L Troxell, et al.
The Breast Journal|June 15, 2016
Impact of Breast Density Legislation on Breast Cancer Risk Assessment and Supplemental Screening: A Survey of 110 Radiology FacilitiesLina Nayak, Kanae K Miyake, Jessica W T Leung, et al.
Journal of Translational Medicine|March 5, 2024
Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockadeShuming Chen, Tracee L McMiller, Abha Soni, et al.
Cancer|October 20, 2015
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapiesRami N Al-Rohil, Ashley J Tarasen, J Andrew Carlson, et al.
Nature Medicine|August 8, 2018
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumabDavid R Gandara, Sarah M Paul, Marcin Kowanetz, et al.
Journal for Immunotherapy of Cancer|December 25, 2025
AstroID resource: a scalable, relational database structure for longitudinal biomarker discoveryElizabeth M Will, Benjamin F Green, Scott Carey, et al.
Orphanet Journal of Rare Diseases|May 3, 2015
No evidence of locus heterogeneity in familial microcephaly with or without chorioretinopathy, lymphedema, or mental retardation syndromeMatthieu J Schlögel, Antonella Mendola, Elodie Fastré, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 14, 2005
Lecozotan (SRA-333): a selective serotonin 1A receptor antagonist that enhances the stimulated release of glutamate and acetylcholine in the hippocampus and possesses cognitive-enhancing propertiesL E Schechter, D L Smith, S Rosenzweig-Lipson, et al.
Journal of Medicinal Chemistry|October 24, 2007
Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonistDerek C Cole, Joseph R Stock, William J Lennox, et al.
Pageof 182